57 related articles for article (PubMed ID: 12181445)
1. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Sampath D; Shi Z; Plunkett W
Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
[TBL] [Abstract][Full Text] [Related]
2. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.
Chen MS; Ryan CE; Piwnica-Worms H
Mol Cell Biol; 2003 Nov; 23(21):7488-97. PubMed ID: 14559997
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.
Sever-Chroneos Z; Angus SP; Fribourg AF; Wan H; Todorov I; Knudsen KE; Knudsen ES
Mol Cell Biol; 2001 Jun; 21(12):4032-45. PubMed ID: 11359910
[TBL] [Abstract][Full Text] [Related]
4. How adeno-associated virus Rep78 protein arrests cells completely in S phase.
Berthet C; Raj K; Saudan P; Beard P
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13634-9. PubMed ID: 16157891
[TBL] [Abstract][Full Text] [Related]
5. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability.
Mailand N; Podtelejnikov AV; Groth A; Mann M; Bartek J; Lukas J
EMBO J; 2002 Nov; 21(21):5911-20. PubMed ID: 12411508
[TBL] [Abstract][Full Text] [Related]
6. A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.
Aoyagi Y; Masuko N; Ohkubo S; Kitade M; Nagai K; Okazaki S; Wierzba K; Terada T; Sugimoto Y; Yamada Y
Cancer Sci; 2005 Sep; 96(9):614-9. PubMed ID: 16128747
[TBL] [Abstract][Full Text] [Related]
7. Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction.
Honaker Y; Piwnica-Worms H
Oncogene; 2010 Jun; 29(23):3324-34. PubMed ID: 20348946
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.
Ohashi M; Sugikawa E; Nakanishi N
Jpn J Cancer Res; 1995 Sep; 86(9):819-27. PubMed ID: 7591958
[TBL] [Abstract][Full Text] [Related]
9. PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression.
Chen Y; Ji Y; Liu S; Liu Y; Feng W; Jin L
Cancer Cell Int; 2022 Jan; 22(1):19. PubMed ID: 35016691
[TBL] [Abstract][Full Text] [Related]
10. Time varying causal network reconstruction of a mouse cell cycle.
Masnadi-Shirazi M; Maurya MR; Pao G; Ke E; Verma IM; Subramaniam S
BMC Bioinformatics; 2019 May; 20(1):294. PubMed ID: 31142274
[TBL] [Abstract][Full Text] [Related]
11. PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer.
Jiang Y; Dai H; Li Y; Yin J; Guo S; Lin SY; McGrail DJ
Int J Cancer; 2019 Mar; 144(5):1092-1103. PubMed ID: 30152517
[TBL] [Abstract][Full Text] [Related]
12. Sodium fluoride causes hepatocellular S-phase arrest by activating ATM-p53-p21 and ATR-Chk1-Cdc25A pathways in mice.
Liu H; Luo Q; Cui H; Deng H; Kuang P; Lu Y; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L
Oncotarget; 2018 Jan; 9(4):4318-4337. PubMed ID: 29435105
[TBL] [Abstract][Full Text] [Related]
13. Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.
Zemanova J; Hylse O; Collakova J; Vesely P; Oltova A; Borsky M; Zaprazna K; Kasparkova M; Janovska P; Verner J; Kohoutek J; Dzimkova M; Bryja V; Jaskova Z; Brychtova Y; Paruch K; Trbusek M
Oncotarget; 2016 Sep; 7(38):62091-62106. PubMed ID: 27556692
[TBL] [Abstract][Full Text] [Related]
14. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode.
Huang X; Cheng CC; Fischmann TO; Duca JS; Yang X; Richards M; Shipps GW
ACS Med Chem Lett; 2012 Feb; 3(2):123-8. PubMed ID: 24900442
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.
Ladd B; Ackroyd JJ; Hicks JK; Canman CE; Flanagan SA; Shewach DS
DNA Repair (Amst); 2013 Dec; 12(12):1114-21. PubMed ID: 24231389
[TBL] [Abstract][Full Text] [Related]
17. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma.
Fernández-Pérez MP; Montenegro MF; Sáez-Ayala M; Sánchez-del-Campo L; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
Neoplasia; 2013 Jul; 15(7):826-39. PubMed ID: 23814494
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.
Schenk EL; Koh BD; Flatten KS; Peterson KL; Parry D; Hess AD; Smith BD; Karp JE; Karnitz LM; Kaufmann SH
Clin Cancer Res; 2012 Oct; 18(19):5364-73. PubMed ID: 22869869
[TBL] [Abstract][Full Text] [Related]
19. DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells.
Wang X; Lui VC; Poon RT; Lu P; Poon RY
Stem Cells; 2009 Mar; 27(3):568-76. PubMed ID: 19259937
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
